Effect of Magnesium Sulphate on Neostigmine

NCT03020706 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 166

Last updated 2017-01-13

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effect of magnesium sulphate on neostigmine-induced reversal of neuromuscular block by rocuronium

Conditions

  • Neuromuscular Blockade

Interventions

DRUG

Magnesium Sulfate, Injectable

magnesium sulphate intravenous administration during general anesthesia

Sponsors & Collaborators

  • Seoul National University Hospital

    collaborator OTHER
  • Gachon University Gil Medical Center

    lead OTHER

Principal Investigators

  • Sang-Hwan Do, MD, Ph D · Seoul National University Bundang Hospital

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2017-01-31
Completion
2017-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03020706 on ClinicalTrials.gov